Office of Dietary Supplements 2010-2014 Strategic Plan, 71016-71017 [E8-27791]
Download as PDF
<![CDATA[
71016
Federal Register / Vol. 73, No. 227 / Monday, November 24, 2008 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group, NHLBI
Institutional Training Mechanism Review
Committee.
Date: December 12, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Four Points by Sheraton/BWI, 7032
Elm Road, Baltimore, MD 21240.
Contact Person: Charles Joyce, Ph.D.,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7196, Bethesda, MD 20892–7924, 301–435–
0288, cjoyce@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: November 14, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–27796 Filed 11–21–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sroberts on PROD1PC70 with NOTICES
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Aug<31>2005
19:32 Nov 21, 2008
Jkt 217001
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel.
Date: December 3–4, 2008.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Tuscan Inn, 495 Jefferson Street,
San Francisco, CA 94109.
Contact Person: Phillip F. Wiethorn,
Scientific Review Administrator, DHHS/NIH/
NINDS/DER/SRB, 6001 Executive Boulevard;
Msc 9529, Neuroscience Center; Room 3203,
Bethesda, MD 20892–9529, (301) 496–5388,
wiethorp@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel Reviewer Conflicts.
Date: December 5, 2008.
Time: 4 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Joann McConnell, PhD.,
Scientific Review Administrator, Scientific
Review Branch, NIH/NINDS/Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
Msc 9529, Bethesda, MD 20892–9529, (301)
496–5324, mcconnej@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: November 17, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–27798 Filed 11–21–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of Dietary Supplements 2010–
2014 Strategic Plan
Notice of Opportunity for Public
Comment and Public Meetings.
ACTION:
SUMMARY: The Office of Dietary
Supplements (ODS) at the National
Institutes of Health (NIH) has initiated
a strategic planning process that will
culminate in the ODS Strategic Plan for
2010–2014. To assist with this process,
the ODS requests input from research
communities—academic, government,
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
and industry—and from other interested
parties. The overall purpose of the
strategic planning effort is to identify
both new opportunities and emerging
needs for incorporation in the
programmatic efforts of the Office. A
background paper has been prepared, A
Report to the Public, that summarizes
progress in four key areas of ODS
activity. The background paper and
related information are available on the
ODS Web site at https://ods.od.nih.gov/
strategicplan.
Public comment can be sent directly
to ODS or through the public Webinars
ODS will hold on January 29, 2009,
February 3, 2009, February 11, 2009,
and February 19, 2009. The section on
Public Participation (below) gives
details for the Webinars.
DATES: In order to ensure full
consideration, all responses must be
submitted by midnight, March 31, 2009.
ADDRESSES: Interested individuals and
organizations should submit their
responses to ODSplan@od.nih.gov.
FOR FURTHER INFORMATION CONTACT: Julia
B. Freeman, Ph.D., Office of Dietary
Supplements, National Institutes of
Health, 6100 Executive Boulevard,
Room 3B01, Bethesda, MD 20892–7517,
Phone: 301–496–0187, Fax: 301–480–
1845, E-mail: ODSplan@od.nih.gov.
SUPPLEMENTARY INFORMATION:
Background
The mission of the Office of Dietary
Supplements (ODS) is to strengthen
knowledge and understanding of dietary
supplements by evaluating scientific
information, stimulating and supporting
research, disseminating research results,
and educating the public to foster an
enhanced quality of life and health for
the U.S. population. The ODS was
established in the Office of the Director,
NIH, in 1995 as a major provision of the
Dietary Supplement Health and
Education Act of 1994 (DSHEA). A key
early activity was the development of
the Strategic Plan for 1998–2003 to set
out goals for program development. The
Strategic Plan was prepared with
considerable input from NIH Institutes
and Centers, other Federal Agencies,
consumers, and other interested parties.
The original five-year plan was revised
for 2004–2009.
The five strategic goals for ODS have
been:
1. Expand the evaluation of the role
of dietary supplements in disease
prevention and in reduction of risk
factors associated with disease.
2. Foster research that evaluates the
role of dietary supplements in
maintaining and improving optimal
E:\FR\FM\24NON1.SGM
24NON1
Federal Register / Vol. 73, No. 227 / Monday, November 24, 2008 / Notices
sroberts on PROD1PC70 with NOTICES
physical and mental health and
performance.
3. Stimulate and support research to
further understanding of the
biochemical and cellular effects of
dietary supplements on biological
systems and their physiological impact
across the life cycle.
4. Promote and support the
development and improvement of
methodologies appropriate to the
scientific study of dietary supplement
ingredients.
5. Expand and conduct outreach
efforts that inform and educate the
public, health care providers, and
scientists about the benefits and risks of
dietary supplements.
ODS is re-examining its Strategic Plan
and desires public comment on the
progress of its programs and on future
needs and opportunities for program
activities. A background paper, A
Report to the Public, has been prepared
that summarizes progress in four key
areas of ODS activities. ODS solicits
comments on and suggestions for its
future activities. The background paper
and related information are available on
the ODS Web site at https://
ods.od.nih.gov/strategicplan. Guidance
is being requested from all interested
parties on these important issues.
• Are the current strategic goals
adequate?
• Is ODS meeting its stakeholders’
needs?
• In the future, should some of ODS’s
current programs or activities be given
higher (or lower) priority?
• How can ODS more effectively
provide useful information to the ODS
user community, including consumers,
investigators, practitioners, industry,
media, policy makers, government, and
other interested parties?
Public Participation
ODS will hold a series of four
Webinars at the times and topics listed
below to hear comments on and
suggestions for ODS initiatives for
possible inclusion in the 2010–2014
ODS Strategic Plan. The topic is taken
from the four areas described in the
background paper, A Report to the
Public. Each Webinar will begin with
brief comments by a Federal partner and
a stakeholder on the topic of that
Webinar. The remainder of each
Webinar will be devoted to hearing
public comments.
Research Support—Thursday, January
29, 2009, 1–2 p.m. EST.
Research support is through
cofunding of NIH grants, including
botanical research centers, individual
research grants, training, and
conferences.
VerDate Aug<31>2005
19:32 Nov 21, 2008
Jkt 217001
Research Tools—Tuesday, February 3,
2009, 2–3 p.m. EST.
Research tools refers to the promotion
and support for the development and
improvement of methodologies
appropriate to the scientific study of
dietary supplement ingredients,
including analytic methodologies and
reference materials, surveys of dietary
supplement use, databases to analyze
survey results, and evidence-based
reviews of key dietary supplements.
Science-Policy—Wednesday,
February 11, 2009, 1–2 p.m. EST.
Science-policy covers current ODS
collaborations to collect information on
scientific issues that is needed for
policy discussions. Three current
collaborations include the vitamin D
initiative, the use of dietary
supplements by military personnel, and
nutrient reference intake values.
Communications—Thursday,
February 19, 2009, 2–3 p.m. EST.
Communications includes outreach
and education on dietary supplements
through the ODS Web site and
information developed by fact sheets,
newsletters, and through databases on
scientific literature and research on
dietary supplements.
The Webinars are open to the public
with attendance limited by individual
access to the Internet and a phone and
by the availability of open
teleconference phone lines. Members of
the public who wish to make an oral
comment should indicate this when
registering for the meeting. Instructions
for registering can be found on the ODS
Web site: https://ods.od.nih.gov/
strategicplan.
Oral comments will be limited to
three minutes and may be accompanied
by a PowerPoint presentation provided
that the presentation is submitted no
later than 2 days before the scheduled
Webinar. Individuals who register to
speak will be assigned in the order in
which they registered. Due to time
constraints, only one representative
from each organization will be allotted
time for oral presentation. If time
permits, those who wish to make a brief
oral statement and have not preregistered to make a comment, will be
able to do so.
Archives of the Webinars will be
posted on the ODS Web site and may be
viewed at any time. We encourage
individuals unable to participate in a
live Webinar and all interested parties
to send written comments by mail, fax,
or electronically (see CONTACT
INFORMATION, above.) When mailing or
faxing written comments, please
provide, if possible, an electronic
version via e-mail.
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
71017
Dated: November 10, 2008.
Paul M. Coates,
Director, Office of Dietary Supplements,
Office of the Director, National Institutes of
Health.
[FR Doc. E8–27791 Filed 11–21–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: GPRA Client
Outcomes for the Substance Abuse and
Mental Health Services Administration
(SAMHSA)—(OMB No. 0930–0208)—
Revision
SAMHSA’s Center for Substance
Abuse Treatment (CSAT) is responsible
for collecting data from discretionary
services grants and contracts where
client outcomes are to be assessed at
three points (intake, discharge, and
post-intake). SAMHSA’s CSAT-funded
projects are required to submit these
data as a contingency of their award.
The analysis of the data also will help
determine whether the goal of reducing
health and social costs of drug use to the
public is being achieved.
The primary purpose of this data
collection activity is to meet the
E:\FR\FM\24NON1.SGM
24NON1
]]>Agencies
[Federal Register Volume 73, Number 227 (Monday, November 24, 2008)]
[Notices]
[Pages 71016-71017]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-27791]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of Dietary Supplements 2010-2014 Strategic Plan
ACTION: Notice of Opportunity for Public Comment and Public Meetings.
-----------------------------------------------------------------------
SUMMARY: The Office of Dietary Supplements (ODS) at the National
Institutes of Health (NIH) has initiated a strategic planning process
that will culminate in the ODS Strategic Plan for 2010-2014. To assist
with this process, the ODS requests input from research communities--
academic, government, and industry--and from other interested parties.
The overall purpose of the strategic planning effort is to identify
both new opportunities and emerging needs for incorporation in the
programmatic efforts of the Office. A background paper has been
prepared, A Report to the Public, that summarizes progress in four key
areas of ODS activity. The background paper and related information are
available on the ODS Web site at https://ods.od.nih.gov/strategicplan.
Public comment can be sent directly to ODS or through the public
Webinars ODS will hold on January 29, 2009, February 3, 2009, February
11, 2009, and February 19, 2009. The section on Public Participation
(below) gives details for the Webinars.
DATES: In order to ensure full consideration, all responses must be
submitted by midnight, March 31, 2009.
ADDRESSES: Interested individuals and organizations should submit their
responses to ODSplan@od.nih.gov.
FOR FURTHER INFORMATION CONTACT: Julia B. Freeman, Ph.D., Office of
Dietary Supplements, National Institutes of Health, 6100 Executive
Boulevard, Room 3B01, Bethesda, MD 20892-7517, Phone: 301-496-0187,
Fax: 301-480-1845, E-mail: ODSplan@od.nih.gov.
SUPPLEMENTARY INFORMATION:
Background
The mission of the Office of Dietary Supplements (ODS) is to
strengthen knowledge and understanding of dietary supplements by
evaluating scientific information, stimulating and supporting research,
disseminating research results, and educating the public to foster an
enhanced quality of life and health for the U.S. population. The ODS
was established in the Office of the Director, NIH, in 1995 as a major
provision of the Dietary Supplement Health and Education Act of 1994
(DSHEA). A key early activity was the development of the Strategic Plan
for 1998-2003 to set out goals for program development. The Strategic
Plan was prepared with considerable input from NIH Institutes and
Centers, other Federal Agencies, consumers, and other interested
parties. The original five-year plan was revised for 2004-2009.
The five strategic goals for ODS have been:
1. Expand the evaluation of the role of dietary supplements in
disease prevention and in reduction of risk factors associated with
disease.
2. Foster research that evaluates the role of dietary supplements
in maintaining and improving optimal
[[Page 71017]]
physical and mental health and performance.
3. Stimulate and support research to further understanding of the
biochemical and cellular effects of dietary supplements on biological
systems and their physiological impact across the life cycle.
4. Promote and support the development and improvement of
methodologies appropriate to the scientific study of dietary supplement
ingredients.
5. Expand and conduct outreach efforts that inform and educate the
public, health care providers, and scientists about the benefits and
risks of dietary supplements.
ODS is re-examining its Strategic Plan and desires public comment
on the progress of its programs and on future needs and opportunities
for program activities. A background paper, A Report to the Public, has
been prepared that summarizes progress in four key areas of ODS
activities. ODS solicits comments on and suggestions for its future
activities. The background paper and related information are available
on the ODS Web site at https://ods.od.nih.gov/strategicplan. Guidance is
being requested from all interested parties on these important issues.
Are the current strategic goals adequate?
Is ODS meeting its stakeholders' needs?
In the future, should some of ODS's current programs or
activities be given higher (or lower) priority?
How can ODS more effectively provide useful information to
the ODS user community, including consumers, investigators,
practitioners, industry, media, policy makers, government, and other
interested parties?
Public Participation
ODS will hold a series of four Webinars at the times and topics
listed below to hear comments on and suggestions for ODS initiatives
for possible inclusion in the 2010-2014 ODS Strategic Plan. The topic
is taken from the four areas described in the background paper, A
Report to the Public. Each Webinar will begin with brief comments by a
Federal partner and a stakeholder on the topic of that Webinar. The
remainder of each Webinar will be devoted to hearing public comments.
Research Support--Thursday, January 29, 2009, 1-2 p.m. EST.
Research support is through cofunding of NIH grants, including
botanical research centers, individual research grants, training, and
conferences.
Research Tools--Tuesday, February 3, 2009, 2-3 p.m. EST.
Research tools refers to the promotion and support for the
development and improvement of methodologies appropriate to the
scientific study of dietary supplement ingredients, including analytic
methodologies and reference materials, surveys of dietary supplement
use, databases to analyze survey results, and evidence-based reviews of
key dietary supplements.
Science-Policy--Wednesday, February 11, 2009, 1-2 p.m. EST.
Science-policy covers current ODS collaborations to collect
information on scientific issues that is needed for policy discussions.
Three current collaborations include the vitamin D initiative, the use
of dietary supplements by military personnel, and nutrient reference
intake values.
Communications--Thursday, February 19, 2009, 2-3 p.m. EST.
Communications includes outreach and education on dietary
supplements through the ODS Web site and information developed by fact
sheets, newsletters, and through databases on scientific literature and
research on dietary supplements.
The Webinars are open to the public with attendance limited by
individual access to the Internet and a phone and by the availability
of open teleconference phone lines. Members of the public who wish to
make an oral comment should indicate this when registering for the
meeting. Instructions for registering can be found on the ODS Web site:
https://ods.od.nih.gov/strategicplan.
Oral comments will be limited to three minutes and may be
accompanied by a PowerPoint presentation provided that the presentation
is submitted no later than 2 days before the scheduled Webinar.
Individuals who register to speak will be assigned in the order in
which they registered. Due to time constraints, only one representative
from each organization will be allotted time for oral presentation. If
time permits, those who wish to make a brief oral statement and have
not pre-registered to make a comment, will be able to do so.
Archives of the Webinars will be posted on the ODS Web site and may
be viewed at any time. We encourage individuals unable to participate
in a live Webinar and all interested parties to send written comments
by mail, fax, or electronically (see CONTACT INFORMATION, above.) When
mailing or faxing written comments, please provide, if possible, an
electronic version via e-mail.
Dated: November 10, 2008.
Paul M. Coates,
Director, Office of Dietary Supplements, Office of the Director,
National Institutes of Health.
[FR Doc. E8-27791 Filed 11-21-08; 8:45 am]
BILLING CODE 4140-01-P
